Wall Street brokerages predict that U.S. Physical Therapy, Inc. (NYSE:USPH) will report $112.28 million in sales for the current quarter, according to Zacks Investment Research. Two analysts have issued estimates for U.S. Physical Therapy’s earnings, with estimates ranging from $112.11 million to $112.45 million. U.S. Physical Therapy reported sales of $103.03 million during the same quarter last year, which would suggest a positive year over year growth rate of 9%. The firm is expected to report its next quarterly earnings results before the market opens on Thursday, November 1st.
According to Zacks, analysts expect that U.S. Physical Therapy will report full year sales of $452.10 million for the current fiscal year, with estimates ranging from $452.09 million to $452.11 million. For the next year, analysts expect that the company will post sales of $478.82 million, with estimates ranging from $471.32 million to $486.31 million. Zacks Investment Research’s sales averages are an average based on a survey of sell-side research firms that follow U.S. Physical Therapy.
U.S. Physical Therapy (NYSE:USPH) last announced its earnings results on Thursday, August 2nd. The company reported $0.73 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.68 by $0.05. U.S. Physical Therapy had a net margin of 5.03% and a return on equity of 13.81%. The business had revenue of $115.10 million for the quarter, compared to analyst estimates of $111.77 million. During the same period last year, the firm posted $0.59 earnings per share. The company’s revenue for the quarter was up 10.4% compared to the same quarter last year.
USPH has been the subject of several recent research reports. Zacks Investment Research raised U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $129.00 price target for the company in a report on Tuesday, August 7th. Jefferies Financial Group reaffirmed a “hold” rating and set a $105.00 price target on shares of U.S. Physical Therapy in a report on Friday, August 3rd. Barrington Research reaffirmed a “hold” rating on shares of U.S. Physical Therapy in a report on Friday, August 3rd. Finally, ValuEngine raised U.S. Physical Therapy from a “buy” rating to a “strong-buy” rating in a report on Tuesday, June 26th. Five research analysts have rated the stock with a hold rating, one has assigned a buy rating and one has assigned a strong buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $108.00.
In other U.S. Physical Therapy news, Director Mark J. Brookner sold 625 shares of the firm’s stock in a transaction on Friday, September 7th. The stock was sold at an average price of $128.50, for a total value of $80,312.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Christopher J. Reading sold 1,232 shares of the firm’s stock in a transaction on Tuesday, August 7th. The shares were sold at an average price of $116.29, for a total value of $143,269.28. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 32,054 shares of company stock valued at $3,713,012. Corporate insiders own 2.50% of the company’s stock.
A number of institutional investors have recently added to or reduced their stakes in USPH. BTIM Corp. acquired a new stake in U.S. Physical Therapy in the second quarter valued at $21,417,000. Riverbridge Partners LLC lifted its holdings in U.S. Physical Therapy by 45.6% in the second quarter. Riverbridge Partners LLC now owns 494,386 shares of the company’s stock valued at $47,461,000 after acquiring an additional 154,915 shares during the period. BlackRock Inc. lifted its holdings in U.S. Physical Therapy by 6.4% in the second quarter. BlackRock Inc. now owns 1,748,408 shares of the company’s stock valued at $167,847,000 after acquiring an additional 104,499 shares during the period. Carillon Tower Advisers Inc. acquired a new stake in U.S. Physical Therapy in the first quarter valued at $6,731,000. Finally, First Trust Advisors LP acquired a new stake in U.S. Physical Therapy in the second quarter valued at $4,942,000. 98.17% of the stock is owned by institutional investors.
Shares of NYSE USPH traded down $3.74 during mid-day trading on Monday, hitting $105.87. 123,590 shares of the company were exchanged, compared to its average volume of 56,180. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.06 and a quick ratio of 2.06. U.S. Physical Therapy has a 1-year low of $62.78 and a 1-year high of $129.65. The company has a market cap of $1.50 billion, a PE ratio of 50.90, a P/E/G ratio of 4.20 and a beta of 1.12.
U.S. Physical Therapy Company Profile
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.